RU2019109061A - Composition for the treatment of gynecological and proctological diseases accompanied by oxidative stress - Google Patents

Composition for the treatment of gynecological and proctological diseases accompanied by oxidative stress Download PDF

Info

Publication number
RU2019109061A
RU2019109061A RU2019109061A RU2019109061A RU2019109061A RU 2019109061 A RU2019109061 A RU 2019109061A RU 2019109061 A RU2019109061 A RU 2019109061A RU 2019109061 A RU2019109061 A RU 2019109061A RU 2019109061 A RU2019109061 A RU 2019109061A
Authority
RU
Russia
Prior art keywords
mixture
concentration
polycation
active substance
mixing
Prior art date
Application number
RU2019109061A
Other languages
Russian (ru)
Other versions
RU2733948C2 (en
RU2019109061A3 (en
Inventor
Петр Владимирович Горелкин
Александр Сергеевич Ерофеев
Наталья Львовна Клячко
Александр Николаевич Ванеев
Ольга Алексеевна Кост
Наталья Борисовна Чеснокова
Ольга Валерьевна Безнос
Николай Леонидович Еремеев
Александр Георгиевич Мажуга
Original Assignee
Общество с ограниченной ответственностью "Медицинские нанотехнологии"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Медицинские нанотехнологии" filed Critical Общество с ограниченной ответственностью "Медицинские нанотехнологии"
Priority to RU2019109061A priority Critical patent/RU2733948C2/en
Publication of RU2019109061A publication Critical patent/RU2019109061A/en
Publication of RU2019109061A3 publication Critical patent/RU2019109061A3/ru
Application granted granted Critical
Publication of RU2733948C2 publication Critical patent/RU2733948C2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/11Aldehydes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Claims (2)

Композиция для лечения гинекологических и проктологических заболеваний, сопровождающихся окислительным стрессом, состоящая из антиоксидантного действующего вещества и основы, отличающаяся тем, что в качестве действующего вещества она содержит частицы, полученные путем смешения буферных растворов антиоксидантного фермента супероксиддисмутазы в концентрации 2,5-10,0 мг/мл и поликатиона в концентрации 2,5-10,0 мг/мл, где поликатион выбирают из группы, включающей протамин, полилизин и полиаргинин, перемешивания и выдерживания смеси с последующими добавлением в нее буферного раствора полианиона в концентрации 2,5-10,0 мг/мл, где полианион представляет собой блок-сополимер полиглутаминовой кислоты и полиэтиленгликоля или блок-сополимер полиаспарагиновой кислоты и полиэтиленгликоля, перемешиванием и выдерживанием полученной смеси, добавлением в нее водного раствора глутарового альдегида, взятого в количестве, обеспечивающем его мольное соотношение с аминогруппами поликатиона 0,3-1,5, выдерживанием смеси, добавлением в смесь водного раствора боргидрида натрия в концентрации 1-2 мг/мл, очисткой смеси с использованием мембранной фильтрующей системы с пределом пропускания 90-130 килодальтон, лиофильной сушкой очищенной смеси и смешением лиофилизата с основой, при следующем соотношении компонентов, мас. %:Composition for the treatment of gynecological and proctological diseases accompanied by oxidative stress, consisting of an antioxidant active substance and a base, characterized in that as an active substance it contains particles obtained by mixing buffer solutions of the antioxidant enzyme superoxide dismutase at a concentration of 2.5-10.0 mg / ml and polycation at a concentration of 2.5-10.0 mg / ml, where the polycation is selected from the group including protamine, polylysine and polyarginine, stirring and maintaining the mixture, followed by adding a buffer solution of polyanion at a concentration of 2.5-10, 0 mg / ml, where the polyanion is a block copolymer of polyglutamic acid and polyethylene glycol or a block copolymer of polyaspartic acid and polyethylene glycol, stirring and maintaining the resulting mixture, adding an aqueous solution of glutaraldehyde, taken in an amount that provides its molar ratio with the amino groups of the polycation 0.3-1.5, withstanding mixing the mixture, adding an aqueous solution of sodium borohydride to the mixture at a concentration of 1-2 mg / ml, purifying the mixture using a membrane filter system with a transmission limit of 90-130 kilodaltons, freeze drying of the purified mixture and mixing the lyophilisate with the base, with the following ratio of components, wt ... %: Действующее веществоActive substance 0,01-20,000.01-20.00 ОсноваThe basis ОстальноеRest
RU2019109061A 2019-03-28 2019-03-28 Composition for treating gynaecological and proctologic diseases accompanied by oxidative stress RU2733948C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2019109061A RU2733948C2 (en) 2019-03-28 2019-03-28 Composition for treating gynaecological and proctologic diseases accompanied by oxidative stress

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2019109061A RU2733948C2 (en) 2019-03-28 2019-03-28 Composition for treating gynaecological and proctologic diseases accompanied by oxidative stress

Publications (3)

Publication Number Publication Date
RU2019109061A true RU2019109061A (en) 2020-09-28
RU2019109061A3 RU2019109061A3 (en) 2020-09-28
RU2733948C2 RU2733948C2 (en) 2020-10-08

Family

ID=72927119

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019109061A RU2733948C2 (en) 2019-03-28 2019-03-28 Composition for treating gynaecological and proctologic diseases accompanied by oxidative stress

Country Status (1)

Country Link
RU (1) RU2733948C2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2293558C2 (en) * 2005-05-05 2007-02-20 Глущенко Оксана Ивановна Agent for treatment of gynecological and proctological diseases
RU2526904C2 (en) * 2007-05-11 2014-08-27 Дзе Борд Оф Риджентс Оф Дзе Юнивёрсити Оф Небраска Compositions for protein delivery and methods of their application
RU2552340C1 (en) * 2013-11-29 2015-06-10 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Nanoparticles of antioxidant enzyme superoxide dismutase in form of polyelectrolyte complex of enzyme-polycation-polyanion compound and method for production thereof

Also Published As

Publication number Publication date
RU2733948C2 (en) 2020-10-08
RU2019109061A3 (en) 2020-09-28

Similar Documents

Publication Publication Date Title
KR102659499B1 (en) Epinastin-containing eye drops
RU2019109061A (en) Composition for the treatment of gynecological and proctological diseases accompanied by oxidative stress
JP6394957B2 (en) Eye drops
RU2010140760A (en) ANTIBACTERIAL MEANS
RU2007144167A (en) BIOLOGICALLY ACTIVE FOOD ADDITIVE
RU2013119431A (en) RHOPALURUS JUNCEUS SCORPIO PEPTIDES AND PHARMACEUTICAL COMPOSITION
RU2447886C1 (en) Preparation for correcting metabolic processes and improving natural body resistance in animals
RU2019109058A (en) Composition that reduces oxidative stress in the eye
US20220031805A1 (en) Therapeutic method of treatment for inhibiting tumor development using tamm-horsfall glycoprotein (thp) as immunostimulating drug and compositions
RU2005104747A (en) THE DRUG FOR THE TREATMENT OF POST-UNIVERSAL PURULAR-CATARAL ENDOMETRITIS AND MASTITIS IN COWS AND METHODS OF ITS APPLICATION
US20150374837A1 (en) Antibacterial agent for treating infectious diseases of bacterial origin
RU2629819C1 (en) Antibacterial composition based on chitosan and lysostaphin
RU2566725C1 (en) Combination drug for parenteral administration containing methylethyl pyridinol hydrochloride or succinate and riboflavin
RU2004120848A (en) COMPOSITION FOR LOCAL PREVENTIVE TREATMENT OF VARICOSE DISEASE
RU2011124647A (en) Ointment with extract of larvae of large wax moth and extract of propolis for prophylaxis and complex treatment of viral infection
RU2009108917A (en) ORGANIC DRUG
RU2392929C2 (en) Agent stimulating hemopoietic stem cell emission in blood flow
RU2012122468A (en) COMPOSITION FOR TREATMENT OF SKIN INJURIES
RU2010146519A (en) COMPOSITION OF BIOLOGICALLY ACTIVE PREPARATIONS TO INCREASE THE SURVIVAL OF STURGEON FISH IN ARTIFICIAL REPRODUCTION
RU2010151556A (en) PHARMACEUTICAL COMPOSITION CONTAINING ENZYMES: LYSOZIM, PEROXIDASE, POVIARGOL AND LIPOSOMES, FOR LOCAL USE
RU2006118961A (en) DRUG FOR TREATMENT OF PYROPLASMOSIS OF DOGS
RU2010148524A (en) INHALATION MEDICINAL FORM OF POLYSIALIZED I HUMAN DESOXYRIBONUCLEASE AND METHOD FOR ITS PREPARATION
RU2502504C1 (en) Antiherpetic agent
RU2010126820A (en) PREBIOTIC, STIMULATING VAGINAL LACTOFLORA GROWTH
RU2008100977A (en) "DIARON" PREPARATION FOR TREATMENT OF ACUTE GASTROINTESTINAL DISEASES OF NEWBORN CALVES

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20210329

NF4A Reinstatement of patent

Effective date: 20220401